| Title |
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
|
|---|---|
| Published in |
Psychopharmacology, May 2019
|
| DOI | 10.1007/s00213-019-05249-5 |
| Pubmed ID | |
| Authors |
Michael C. Mithoefer, Allison A. Feduccia, Lisa Jerome, Anne Mithoefer, Mark Wagner, Zach Walsh, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin |
X Demographics
The data shown below were collected from the profiles of 112 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 34 | 30% |
| United Kingdom | 5 | 4% |
| Canada | 5 | 4% |
| Australia | 4 | 4% |
| Iceland | 2 | 2% |
| Italy | 1 | <1% |
| Brazil | 1 | <1% |
| Bermuda | 1 | <1% |
| Switzerland | 1 | <1% |
| Other | 5 | 4% |
| Unknown | 53 | 47% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 85 | 76% |
| Scientists | 13 | 12% |
| Practitioners (doctors, other healthcare professionals) | 11 | 10% |
| Science communicators (journalists, bloggers, editors) | 3 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 574 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 574 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 111 | 19% |
| Student > Master | 52 | 9% |
| Researcher | 49 | 9% |
| Student > Ph. D. Student | 37 | 6% |
| Student > Doctoral Student | 29 | 5% |
| Other | 76 | 13% |
| Unknown | 220 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 101 | 18% |
| Medicine and Dentistry | 71 | 12% |
| Neuroscience | 42 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 21 | 4% |
| Nursing and Health Professions | 20 | 3% |
| Other | 88 | 15% |
| Unknown | 231 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 954. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2024.
All research outputs
#17,589
of 25,613,746 outputs
Outputs from Psychopharmacology
#3
of 5,351 outputs
Outputs of similar age
#333
of 365,008 outputs
Outputs of similar age from Psychopharmacology
#1
of 59 outputs
Altmetric has tracked 25,613,746 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,351 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,008 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.